Medical News

RSS

Hotspots of fuel consumption in adult brain also show key characteristics of developing brain

Although brain growth slows as individuals age, some regions of the brain continue to develop for longer than others, creating new connections and remodeling existing circuitry.

7 Jan 2014

First patient enrolled in the North American Phase 3 clinical trials for investigational flu treatment drug

BioDefense Therapeutics—a Joint Product Management office within the U.S. Department of Defense—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir (T-705a). The drug is an investigational flu treatment candidate with broad-spectrum potential being developed by BD Tx through a contract with Boston-based MediVector, Inc.

7 Jan 2014

Health law expected to trigger industry hiring spree

On one hand, insurance enrollment figures may be short of the numerical goals that were set earlier in the process, but some people still are predicting that health providers will ramp up hiring in response to knew demand created by the overhaul.

7 Jan 2014

FDA accepts NPS Pharmaceuticals' Natpara BLA for review

NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the U.S. Food and Drug Administration has accepted and filed for review the company's Biologics License Application for Natpara (recombinant human parathyroid hormone 1-84, (rhPTH[1-84])) for the treatment of hypoparathyroidism.

7 Jan 2014

Blueprint Medicines closes $25 million Series B financing

Blueprint Medicines today announced the completion of a $25 million Series B financing. The oncology-focused investor, Nextech Invest Ltd., led the round, which also included founding investors Third Rock Ventures and Fidelity Biosciences as well as public investors Biotech Value Fund, L.P., Casdin Capital, LLC and other undisclosed investors.

7 Jan 2014

Mylan launches Tolterodine Tartrate ER Capsules, 2 mg and 4 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.

7 Jan 2014

Aggression treatment needed for patients with bipolar disorder

Patients with bipolar disorder are at increased risk for aggression, particularly when acutely ill, show results from a longitudinal study.

7 Jan 2014

Substance use ‘dramatically’ high in severe psychosis

Patients with severe psychotic disorders have a risk for smoking, heavy alcohol use, and other drug use that “far exceeds” that documented in patients with mild mental illness, shows a large study.

7 Jan 2014

Fruit smoothies visibly improve skin's appearance

A group of university students are enjoying a specially designed fruit smoothie a day to discover whether it can improve their appearance and make them feel healthier.

7 Jan 2014

Memorial Sloan-Kettering to use Sutro's cell-free protein synthesis technology to produce bispecific antibodies

Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration agreement with Memorial Sloan-Kettering Cancer Center to use Sutro's proprietary cell-free protein synthesis technology to produce bispecific antibodies that were discovered by Memorial Sloan-Kettering for the treatment of neuroblastoma in children.

7 Jan 2014

Elderly people with high serum vitamin E levels less likely to suffer from memory disorders

Elderly people with high serum vitamin E levels are less likely to suffer from memory disorders than their peers with lower levels, according to a study published recently in Experimental Gerontology.

7 Jan 2014

Marriage does not lower poverty rates among poor, single mothers

As the United States marks the 50th anniversary of the War on Poverty this month, a new report suggests one recent weapon in the battle has been a disappointing failure.

7 Jan 2014

Health care spending grew at record slow pace

Americans' spending on health care rose a relatively modest 3.7 percent in 2012 -- slower than the growth of the overall economy -- dropping from 17.3 percent of U.S. spending to 17.2 percent, according to an annual report from the Centers on Medicare & Medicaid Services.

7 Jan 2014

Healthcare Trust of America executes new $300 million senior unsecured loan

Healthcare Trust of America, Inc. announced today that it had executed a new $300 million senior unsecured, 4-year term loan (the "New Term Loan").

7 Jan 2014

Minnesota professor receives Hazelden's Dan Anderson Research Award for hybrid CBT study

Matt G. Kushner, Ph.D., professor of Psychiatry, University of Minnesota (Minneapolis) has earned the latest Dan Anderson Research Award for his study examining the effectiveness of a hybrid cognitive behavioral therapy in the treatment of individuals with co-occurring anxiety disorders and alcohol dependence.

7 Jan 2014